Short-term effects of Poly(I:C) on gut permeability

被引:18
作者
Moyano-Porcile, Valentina [1 ]
Olavarria-Ramirez, Loreto [1 ]
Gonzalez-Arancibia, Camila [1 ]
Bravo, Javier A. [1 ]
Julio-Pieper, Marcela [1 ]
机构
[1] Pontificia Univ Catolica Valparaiso, Fac Ciencias, Inst Quim, Grp NeuroGastroBioquim, Valparaiso, Chile
关键词
Poly(I:C); TLR-3; Intestinal barrier; Intestinal permeability; DOUBLE-STRANDED-RNA; INTESTINAL BARRIER; TNF-ALPHA; TLR3; EXPRESSION; RECEPTOR; PROTEIN; CELLS; MODULATION; ACTIVATION;
D O I
10.1016/j.phrs.2015.06.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The intestinal barrier function depends on an adequate response to pathogens by the epithelium. Toll-like receptor 3 (TLR-3) recognizes double-stranded RNA, a virus-associated molecular pattern. Activation of TLR-3 with Poly(I:C), a synthetic agonist, modulates tissue repair and permeability in other epithelia; however, the effects of local luminal TLR-3 agonists on gut barrier function are unknown. The aim of this investigation was to evaluate short-term effects of Poly(I:C) on rat ileal and colonic permeability ex vivo. We also studied the acute effects of intrarectal administration of Poly(I:C) on colonic barrier function. Ileum tissues displayed decreased transepithelial electrical resistance (TEER) 1 h after incubation with 200 mu g/mL Poly(I:C); however, the mucosa-to-serosa transit of macromolecules (4.4 and 40 kDa dextrans - TD4.4 and FD40, respectively) remained unchanged. Conversely, colon tissue preparations stimulated with 200 mu g/mL Poly(I:C) showed a decreased thinning of the mucosal layer after 2 h and a decreased transit of FD40 after 3 h, in comparison to controls. There was no change in colonic TEER after 3 h of treatment. In addition, colon tissue taken from rats 6 h after an intrarectal administration of 100 mu g Poly(I:C) also showed decreased permeability to FD40 in the everted gut sac assay at 3 h post-extraction. Tissue morphology remained unchanged. Our results suggest that an acute exposure to Poly(I:C) reduces colon permeability to macromolecules but increases ileum permeability to electrolytes/small molecules ex vivo. Although the mechanism associated to these effects needs further investigation, to our knowledge this is the first report of a direct effect of a TLR-3 ligand in intestinal barrier function and may be of significance to understand region-specific interactions between gut mucosa and microbiota. (c) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:130 / 136
页数:7
相关论文
共 37 条
  • [1] TLR signaling in the gut in health and disease
    Abreu, MT
    Fukata, M
    Arditi, M
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (08) : 4453 - 4460
  • [2] Toll-like Receptors 3, 4, and 7 Are Expressed in the Enteric Nervous System and Dorsal Root Ganglia
    Barajon, Isabella
    Serrao, Graziano
    Arnaboldi, Francesca
    Opizzi, Emanuela
    Ripamonti, Gerlomina
    Balsari, Andrea
    Rumio, Cristiano
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2009, 57 (11) : 1013 - 1023
  • [3] New ways of thinking about (and teaching about) intestinal epithelial function
    Barrett, Kim E.
    [J]. ADVANCES IN PHYSIOLOGY EDUCATION, 2008, 32 (01) : 25 - 34
  • [4] Effect of pretreatment with toll-like receptor agonists in a mouse model of herpes simplex virus type 1 encephalitis
    Boivin, Nicolas
    Sergerie, Yan
    Rivest, Serge
    Boivin, Guy
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (05) : 664 - 672
  • [5] Impenetrable barriers or entry portals? The role of cell-cell adhesion during infection
    Bonazzi, Matteo
    Cossart, Pascale
    [J]. JOURNAL OF CELL BIOLOGY, 2011, 195 (03) : 348 - 357
  • [6] Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease
    Cario, E
    Podolsky, DK
    [J]. INFECTION AND IMMUNITY, 2000, 68 (12) : 7010 - 7017
  • [7] Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C
    Cario, E
    Gerken, G
    Podolsky, DK
    [J]. GASTROENTEROLOGY, 2004, 127 (01) : 224 - 238
  • [8] The Gut Immune Barrier and the Blood-Brain Barrier: Are They So Different?
    Daneman, Richard
    Rescigno, Maria
    [J]. IMMUNITY, 2009, 31 (05) : 722 - 735
  • [9] Intestinal barrier: An interface between health and disease
    Farhadi, A
    Banan, A
    Fields, J
    Keshavarzian, A
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (05) : 479 - 497
  • [10] Quantifying tight junction disruption caused by biomimetic pH-sensitive hydrogel drug carriers
    Fisher, O. Z.
    Peppas, N. A.
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2008, 18 (01) : 47 - 50